News Headlines Article

Revise Generic Drug Labeling, Petition Urges
Health Leaders Media

The U.S. Food and Drug Administration should require manufacturers of generic drugs to promptly update warning labels when they learn of new side effects, the healthcare advocacy group Public Citizen said in a petition filed Monday.

At present, generic makers are prohibited by regulations from changing labels unless they have FDA approval, or unless the brand name maker has updated the label first.